Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pone.0103974
Download full text from publisher
References listed on IDEAS
- Bo Hu & Alex Z. Fu, 2010. "Predicting Utility for Joint Health States: A General Framework and a New Nonparametric Estimator," Medical Decision Making, , vol. 30(5), pages 29-39, September.
- Soyon Lee & Rachel Mullin & Jon Blazawski & Craig I Coleman, 2012. "Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation," PLOS ONE, Public Library of Science, vol. 7(10), pages 1-9, October.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Xue Li & Vicki C Tse & Wallis C Y Lau & Bernard M Y Cheung & Gregory Y H Lip & Ian C K Wong & Esther W Chan, 2016. "Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-15, June.
- Alexander V van Schoonhoven & Judith J Gout-Zwart & Marijke J S de Vries & Antoinette D I van Asselt & Evgeni Dvortsin & Pepijn Vemer & Job F M van Boven & Maarten J Postma, 2019. "Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-22, September.
- Lisa A de Jong & Jessie Groeneveld & Jelena Stevanovic & Harrie Rila & Robert G Tieleman & Menno V Huisman & Maarten J Postma & Marinus van Hulst, 2019. "Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-17, September.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Xue Li & Vicki C Tse & Wallis C Y Lau & Bernard M Y Cheung & Gregory Y H Lip & Ian C K Wong & Esther W Chan, 2016. "Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-15, June.
- Brendan L Limone & William L Baker & Jeffrey Kluger & Craig I Coleman, 2013. "Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models," PLOS ONE, Public Library of Science, vol. 8(4), pages 1-15, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0103974. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.